These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39265443)

  • 21. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease
    Liu H; Chen Y; Wen Y; Zhu S; Huang S; He L; Hou S; Lai X; Chen S; Dai Z; Liang J
    J Agric Food Chem; 2021 Aug; 69(31):8671-8683. PubMed ID: 34342231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plant Sterol Ester of
    Han H; Guo Y; Li X; Shi D; Xue T; Wang L; Li Y; Zheng M
    Oxid Med Cell Longev; 2019; 2019():8294141. PubMed ID: 33273997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
    Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
    Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
    Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice.
    Zhang C; Chen X; Zhu RM; Zhang Y; Yu T; Wang H; Zhao H; Zhao M; Ji YL; Chen YH; Meng XH; Wei W; Xu DX
    Toxicol Lett; 2012 Aug; 212(3):229-40. PubMed ID: 22698815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PKA-SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet-Induced Fatty Liver in Mice.
    Hong E; Kang H; Yang G; Oh S; Kim E
    Mol Nutr Food Res; 2023 Oct; 67(20):e2200496. PubMed ID: 37650271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling.
    Chen C; Zhang X
    J Transl Med; 2017 Feb; 15(1):42. PubMed ID: 28222747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of COPII vesicle trafficking to nutrient availability by the IRE1α-XBP1s axis.
    Liu L; Cai J; Wang H; Liang X; Zhou Q; Ding C; Zhu Y; Fu T; Guo Q; Xu Z; Xiao L; Liu J; Yin Y; Fang L; Xue B; Wang Y; Meng ZX; He A; Li JL; Liu Y; Chen XW; Gan Z
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11776-11785. PubMed ID: 31123148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apigenin Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 Cells and High-Fat Diet-Fed Mice.
    Wu L; Guo T; Deng R; Liu L; Yu Y
    J Pharmacol Exp Ther; 2021 Apr; 377(1):146-156. PubMed ID: 33509902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
    Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
    Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis.
    Lan T; Geng XJ; Zhang SJ; Zeng XX; Ying JJ; Xu Y; Liu SY; Li P; Tong YH; Wang W; Mao ZJ; Wang SW
    Phytomedicine; 2024 Jan; 123():155209. PubMed ID: 37984123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
    Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
    Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenite Induces Vascular Endothelial Cell Dysfunction by Activating IRE1α/XBP1s/HIF1α-Dependent ANGII Signaling.
    Xu X; Liu S; Aodengqimuge ; Wang H; Hu M; Xing C; Song L
    Toxicol Sci; 2017 Dec; 160(2):315-328. PubMed ID: 28973481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
    J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.
    Shao M; Shan B; Liu Y; Deng Y; Yan C; Wu Y; Mao T; Qiu Y; Zhou Y; Jiang S; Jia W; Li J; Li J; Rui L; Yang L; Liu Y
    Nat Commun; 2014 Mar; 5():3528. PubMed ID: 24670948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
    Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
    Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
    Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.